Plus Therapeutics, Inc.
(NASDAQ : PSTV)

( )
PSTV After-Hours: () as of PM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Pharmaceuticals Major
symbolcompany%chnglast%shortavg$volume
JNJJohnson & Johnson -0.26%165.190.7%$1305.30m
LLYEli Lilly & Co. 0.57%331.781.1%$1072.82m
ABBVAbbVie, Inc. 0.94%143.331.9%$877.03m
PFEPfizer Inc. -0.47%44.250.9%$815.29m
BMYBristol-Myers Squibb Co. 0.34%71.451.0%$767.68m
MRKMerck & Co., Inc. 0.01%88.400.7%$706.05m
AZNAstraZeneca Plc -0.54%56.731.0%$402.73m
ALNYAlnylam Pharmaceuticals, Inc. -0.11%201.028.2%$225.00m
GSKGSK Plc -1.01%30.400.3%$210.45m
NVSNovartis AG -1.11%77.360.2%$209.93m
IDXXIDEXX Laboratories, Inc. 0.44%350.123.9%$189.64m
GBTGlobal Blood Therapeutics, Inc. 0.00%68.495.4%$183.92m
HZNPHorizon Therapeutics Plc 1.35%67.055.4%$182.38m
NVONovo Nordisk A/S 0.63%106.040.1%$132.75m
SRPTSarepta Therapeutics, Inc. -0.76%110.6212.4%$132.70m

Company Profile

Plus Therapeutics, Inc. is a clinical-stage pharmaceutical company. The firm focuses on the development of chemotherapeutics and radio therapeutics for rare cancers that address unmet medical and market needs. Its products include Rhenium NanoLiposome and DocePLUS. The company was founded by Ralph E. Holmes and Christopher J. Calhoun in July 1996 and is headquartered in Austin, TX.